|
|
HPDL |
4-hydroxyphenylpyruvate dioxygenase like |
|
|
|
|
|
HPS6 |
HPS6 biogenesis of lysosomal organelles complex 2 subunit 3 |
|
|
- Hermansky-Pudlak syndrome (HPS)
|
|
|
HRNR |
hornerin |
|
|
|
|
|
HSBP1 |
heat shock factor binding protein 1 |
- HSF1 activation
- Attenuation phase
- HSF1-dependent transactivation
|
|
|
|
|
HSD17B11 |
hydroxysteroid 17-beta dehydrogenase 11 |
|
|
|
|
|
HSF1 |
heat shock transcription factor 1 |
- Regulation of HSF1-mediated heat shock response
- HSF1 activation
- Attenuation phase
- HSF1-dependent transactivation
- Aggrephagy
- Mitochondrial unfolded protein response (UPRmt)
|
|
|
|
|
HSPA8 |
heat shock protein family A (Hsp70) member 8 |
- Regulation of HSF1-mediated heat shock response
- HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
- Attenuation phase
- HSF1-dependent transactivation
- Lysosome Vesicle Biogenesis
- Golgi Associated Vesicle Biogenesis
- CHL1 interactions
- AUF1 (hnRNP D0) binds and destabilizes mRNA
- Interleukin-4 and Interleukin-13 signaling
- Neutrophil degranulation
- mRNA Splicing - Major Pathway
- Clathrin-mediated endocytosis
- Protein methylation
- GABA synthesis, release, reuptake and degradation
- Lipophagy
- Chaperone Mediated Autophagy
- Late endosomal microautophagy
- Respiratory syncytial virus genome transcription
- PKR-mediated signaling
|
- Dasatinib
- (2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
- Copper
- Artenimol
|
|
|
|
HSPG2 |
heparan sulfate proteoglycan 2 |
- Degradation of the extracellular matrix
- Degradation of the extracellular matrix
- Glycosaminoglycan-protein linkage region biosynthesis
- HS-GAG biosynthesis
- HS-GAG biosynthesis
- HS-GAG degradation
- Integrin cell surface interactions
- Laminin interactions
- Laminin interactions
- Non-integrin membrane-ECM interactions
- Non-integrin membrane-ECM interactions
- ECM proteoglycans
- Defective B4GALT7 causes EDS, progeroid type
- Defective B3GAT3 causes JDSSDHD
- Defective EXT2 causes exostoses 2
- Defective EXT1 causes exostoses 1, TRPS2 and CHDS
- Defective B3GALT6 causes EDSP2 and SEMDJL1
- Attachment and Entry
- Attachment and Entry
- Retinoid metabolism and transport
- Amyloid fiber formation
- Respiratory syncytial virus (RSV) attachment and entry
- RSV-host interactions
- Mechanical load activates signaling by PIEZO1 and integrins in osteocytes
- Formation of the dystrophin-glycoprotein complex (DGC)
|
|
- Heparan sulfate proteoglycan gene defects, including: Dyssegmental dysplasia, Silverman-Handmaker type; Schwartz-Jampel syndrome; Simpson-Golabi-Behmel syndrome, type 1; Omodysplasia 1; Multiple exostoses
|
|
|
HTRA2 |
HtrA serine peptidase 2 |
- Mitochondrial protein degradation
- Mitochondrial unfolded protein response (UPRmt)
|
|
|
|
|
HUWE1 |
HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 |
- Neutrophil degranulation
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
- Syndromic X-linked mental retardation, including: Turner type (MRXST); Siderius type (MRXSSD) ; Cabezas type (MRXC); Raymond type (MRXSR); Type10 (MRXS10); Type14 (MRXS14); Mental retardation with isolated growth hormone deficiency (MRGH)
|
|
|
HYDIN |
HYDIN axonemal central pair apparatus protein |
|
|
|
|
|
HYDIN2 |
HYDIN axonemal central pair apparatus protein 2 (pseudogene) |
|
|
|
|
|
ID1 |
inhibitor of DNA binding 1 |
- Oncogene Induced Senescence
- NGF-stimulated transcription
- Transcriptional and post-translational regulation of MITF-M expression and activity
|
|
|
|
|
IDE |
insulin degrading enzyme |
- Ub-specific processing proteases
- Insulin receptor recycling
- Peroxisomal protein import
- Peroxisomal protein import
|
|
|
|
|
IGF1R |
insulin like growth factor 1 receptor |
- Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
- IRS-related events triggered by IGF1R
- SHC-related events triggered by IGF1R
- Extra-nuclear estrogen signaling
- Respiratory syncytial virus (RSV) attachment and entry
|
- Insulin human
- Insulin lispro
- Insulin glargine
- Insulin pork
- Mecasermin
- Insulin aspart
- Insulin detemir
- Insulin glulisine
- Phosphoaminophosphonic Acid-Adenylate Ester
- ATL1101
- XL228
- rhIGFBP-3
- Linsitinib
- Teprotumumab
- (4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione
- 3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE
- Nandrolone decanoate
- Somatrem
- Insulin beef
- Insulin degludec
- Insulin argine
- Insulin peglispro
- Insulin tregopil
- Dalotuzumab
- Cixutumumab
- Brigatinib
- Mecasermin rinfabate
- BMS-754807
- KW-2450 free base
|
- Synovial sarcoma
- Malignant pleural mesothelioma
|
|
|
IKBIP |
IKBKB interacting protein |
- Regulation of NF-kappa B signaling
|
|
|
|
|
IKBKB |
inhibitor of nuclear factor kappa B kinase subunit beta |
- Activation of NF-kappaB in B cells
- Activation of NF-kappaB in B cells
- ER-Phagosome pathway
- NOD1/2 Signaling Pathway
- TICAM1, RIP1-mediated IKK complex recruitment
- RIP-mediated NFkB activation via ZBP1
- Downstream TCR signaling
- p75NTR recruits signalling complexes
- NF-kB is activated and signals survival
- FCERI mediated NF-kB activation
- TAK1-dependent IKK and NF-kappa-B activation
- Regulation of TNFR1 signaling
- TNFR1-induced NF-kappa-B signaling pathway
- IKBKB deficiency causes SCID
- IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)
- IkBA variant leads to EDA-ID
- CLEC7A (Dectin-1) signaling
- MAP3K8 (TPL2)-dependent MAPK1/3 activation
- Interleukin-1 signaling
- TRAF6 mediated NF-kB activation
- NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
- IRAK1 recruits IKK complex
- IKK complex recruitment mediated by RIP1
- SARS-CoV-2 activates/modulates innate and adaptive immune responses
- IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
- Regulation of NF-kappa B signaling
- PKR-mediated signaling
- SLC15A4:TASL-dependent IRF5 activation
- Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
- Modulation of host responses by IFN-stimulated genes
|
- Mesalazine
- Acetylsalicylic acid
- Auranofin
- Arsenic trioxide
- MLN0415
- Acetylcysteine
- Ertiprotafib
- Fostamatinib
|
|
|
|
IKBKG |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
- Activation of NF-kappaB in B cells
- Activation of NF-kappaB in B cells
- ER-Phagosome pathway
- NOD1/2 Signaling Pathway
- TICAM1, RIP1-mediated IKK complex recruitment
- RIP-mediated NFkB activation via ZBP1
- Downstream TCR signaling
- FCERI mediated NF-kB activation
- TAK1-dependent IKK and NF-kappa-B activation
- activated TAK1 mediates p38 MAPK activation
- JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
- SUMOylation of immune response proteins
- Regulation of TNFR1 signaling
- TNFR1-induced NF-kappa-B signaling pathway
- IKBKB deficiency causes SCID
- IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)
- IkBA variant leads to EDA-ID
- CLEC7A (Dectin-1) signaling
- MAP3K8 (TPL2)-dependent MAPK1/3 activation
- Ub-specific processing proteases
- Ovarian tumor domain proteases
- Interleukin-1 signaling
- TRAF6 mediated NF-kB activation
- NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
- IRAK1 recruits IKK complex
- IKK complex recruitment mediated by RIP1
- SARS-CoV-2 activates/modulates innate and adaptive immune responses
- IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
- Regulation of NF-kappa B signaling
- PKR-mediated signaling
- SLC15A4:TASL-dependent IRF5 activation
- Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
- Modulation of host responses by IFN-stimulated genes
|
|
- Incontinentia pigmenti
- Ectodermal dysplasia associated immunodeficiency (EDA-ID), including the following two diseases: NF-kappa-B essential modulator (NEMO) defect; Inhibitor of kappa-B (I-kappa-B) defect
- Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID); Ectodermal dysplasia, anhidrotic, with immunodeficiency, osteopetrosis, and lymphedema
|
|
|
ILF3 |
interleukin enhancer binding factor 3 |
- Regulation of CDH11 gene transcription
- Regulation of CDH11 gene transcription
- PKR-mediated signaling
|
|
|
|
|
IMMT |
inner membrane mitochondrial protein |
|
|
|